Compton Capital Management Inc Boston Scientific Corp Transaction History

Compton Capital Management Inc

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$39.56 - $47.22 $19,780 - $23,610	-500 Reduced 8.53%	5,365 $248,000
Q3 2022 Nov 08, 2022	SELL	$36.71 - $109.66 $4,588 - $13,707	-125 Reduced 2.09%	5,865 $227,000
Q2 2022 Aug 11, 2022	SELL	$35.24 - $47.1 $52,860 - $70,650	-1,500 Reduced 20.03%	5,990 $223,000
Q3 2021 Nov 10, 2021	SELL	$41.23 - $45.88 $11,132 - $12,387	-270 Reduced 3.48%	7,490 $325,000
Q2 2021 Aug 11, 2021	BUY	$38.58 - $44.24 $6,751 - $7,742	175 Added 2.31%	7,760 $332,000
Q1 2021 May 04, 2021	BUY	$35.27 - $39.67 $2,645 - $2,975	75 Added 1.0%	7,585 $293,000
Q4 2020 Feb 08, 2021	BUY	$33.15 - $41.97 $11,602 - $14,689	350 Added 4.89%	7,510 $270,000
Q3 2020 Nov 12, 2020	SELL	$34.44 - $42.23 $10,332 - $12,668	-300 Reduced 4.02%	7,160 $274,000
Q2 2020 Aug 12, 2020	BUY	$30.19 - $39.11 $9,057 - $11,733	300 Added 4.19%	7,460 $262,000
Q1 2020 May 06, 2020	BUY	$25.83 - $45.71 $15,497 - $27,426	600 Added 9.15%	7,160 $234,000
Q4 2019 Feb 10, 2020	BUY	$37.87 - $45.37 $248,427 - $297,627	6,560 New	6,560 $297,000

1,559

1.18B

6.78M

10.1M

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $141B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

Get notified when there are updates to the investment portfolio of Compton Capital Management Inc , based on Form 13F filings with the SEC.

Stay updated on Compton Capital Management Inc with notifications on news.